This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Reeß, J. Articles by Fiola, M. Search for Related Content PubMed PubMed Citation Articles by Reeß, J. Articles by Fiola, M. Social Bookmarking                         What's this?

Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-la (AVONEX®) therapy

Clinic for Neurology Dietenbronn, 88477 Schwendi, Germany

J. Haas

Clinic for Neurology, Jewish Hospital, 13347 Berlin, Germany

K. Gabriel

Biogen GmbH, 85737 Ismaning, Germany

A. Fuhlrott

Biogen GmbH, 85737 Ismaning, Germany

M. Fiola

Biogen GmbH, 85737 Ismaning, Germany

Interferon beta-la is an established therapy for patients with relapsing-remitting multiple sclerosis (MS). Adverse effects in the first weeks of treatment are common. This open-label, multicenter, randomized, prospective study compared treatment of flu-like symptoms (FLS) with paracetamol versus ibuprofen administered 48 h within interferon injection. The percentage of patients with FLS was comparable between both treatment groups and improved during the course of the study (baseline: paracetamol 92%, ibuprofen 90%; week 12: paracetamol 60%, ibuprofen 57%). More than 75% of patients receiving either paracetamol or ibuprofen reported no or only mild impairment of daily activities. There was no significant difference in general satisfaction or incidence of additional symptoms (weakness, nausea, headache; paracetamol 84.6% patients, ibuprofen 86.0% patients) between the two groups. A significant overall improvement from baseline to week 12 was observed for all parameters studied (paracetamol and ibuprofen groups were pooled). These results indicate that neither the paracetamol nor the ibuprofen treatment regimen is better. Multiple Sclerosis (2002) 8, 15-18

Key Words: Key words: adverse events • antipyretics • human • interferon • interferon beta-la • multiple sclerosis • side effects

Multiple Sclerosis, Vol. 8, No. 1 suppl, 15-18 (2002)
DOI: 10.1177/135245850200800104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?